Financial Architects, Inc - INTELLIPHARMACEUTICS INTL IN ownership

INTELLIPHARMACEUTICS INTL IN's ticker is IPCI and the CUSIP is 458173101. A total of 20 filers reported holding INTELLIPHARMACEUTICS INTL IN in Q2 2017. The put-call ratio across all filers is 3.75 and the average weighting 0.0%.

Quarter-by-quarter ownership
Financial Architects, Inc ownership history of INTELLIPHARMACEUTICS INTL IN
ValueSharesWeighting
Q2 2018$1,0000.0%2,0000.0%0.00%
Q1 2018$1,000
-50.0%
2,0000.0%0.00%
Q4 2017$2,0000.0%2,0000.0%0.00%
Q3 2017$2,0000.0%2,000
+81.8%
0.00%
Q2 2017$2,000
-33.3%
1,1000.0%0.00%
-100.0%
Q1 2017$3,0000.0%1,1000.0%0.00%0.0%
Q4 2016$3,0001,1000.00%
Other shareholders
INTELLIPHARMACEUTICS INTL IN shareholders Q2 2017
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 72,787$219,0000.22%
Tekla Capital Management LLC 1,404,000$4,226,0000.20%
FIRST MIDWEST BANK TRUST DIVISION 49,372$149,0000.02%
Tower Research Capital LLC (TRC) 13,287$40,0000.00%
A.R.T. Advisors, LLC 17,910$53,0000.00%
PNC FINANCIAL SERVICES GROUP, INC. 12,000$36,0000.00%
WELLS FARGO & COMPANY/MN 25$00.00%
AMERIPRISE FINANCIAL INC 30,000$90,0000.00%
1832 Asset Management L.P. 12$00.00%
DEUTSCHE BANK AG\ 192,676$579,0000.00%
View complete list of INTELLIPHARMACEUTICS INTL IN shareholders